Geoff Pardo - Gilde Healthcare

team
Venture&Growth

All team members
Geoff Pardo
General Partner Healthtech
Venture&Growth
United States of America

Geoff Pardo

General Partner Healthtech
Venture&Growth

Geoff Pardo joined Gilde Healthcare in 2011 as a Partner working out of the office in Boston/Cambridge, MA and is focusing on Gilde’s investments in North America. He led the investments in Ablative Solutions, Inari Medical (NASDAQ: NARI), Axonics Modulation Technologies (NASDAQ: AXNX), CVRx (NASDAQ: CVRX), InovaLabs (acquired by ResMed), BionX (acquired by Ottobock), Vapotherm (NYSE: VAPO), Vesper Medical, Nalu Medical, Spire Health and Eargo (NASDAQ: EAR). He represents Gilde as a member of the board of directors for each company.

Previously, he was a Partner at Spray Venture Partners where he led investments into Interlace Medical (sold to Hologic), Solace Therapeutics, TearScience (sold to J&J) and Cascade Ophthalmics. He served on the board of Solace, TearScience and Cascade, and was actively involved in Interlace and Conventus Orthopedics.

Geoff also served as President & CEO of Facet Solutions, a spinal implant company focused on treating lumbar spinal stenosis until the company was sold to Globus Medical in 2011. He has also worked at Cardinal Partners as an Associate leading their investing activity in the medical device sector.

Geoff began his career in medical devices as a product manager with Synthes USA.

He has a B.A. with honors in History from Brown University and an M.B.A. from the Wharton School of Business. He is a US citizen based in Gilde Healthcare’s Cambridge, MA office.

Geoff is also the host of the MedTech Talk podcast in which he interviews entrepreneurs and other MedTech investors.

 

 

Dr. Paul Parren

Operational Partner
Paul Parren is an internationally recognized antibody drug innovator and developer. Paul was Head of Preclinical Development and Research at Genmab (2002-2017), translating antibody biology successfully into immunotherapies from discovery to the clinic, including approved...

Michael R. Jaff, DO

Operational Partner
Michael R. Jaff, DO is the Chief Medical Officer and Vice-President of clinical affairs, technology and innovation at Boston Scientific Corporation. A professor of medicine at Harvard Medical School, Dr. Jaff was the President of...

Professor Dr. Rene Bernards

Operational Partner
Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute...